Alterity Therapeutics Enrolls First Patient in Australia in
MELBOURNE, Australia and SAN FRANCISCO, May 10, 2023 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a...
Source: globenewswire.com
📰 Stephen Tisch News
Stephen Tisch News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Stephen Tisch. Real-time updates on events, politics, business and more.
Alterity Therapeutics Enrolls First Patient in Australia in ATH434 Global Phase 2 Clinical Trial in Multiple System Atrophy
MELBOURNE, Australia and SAN FRANCISCO, May 10, 2023 -- Alterity Therapeutics , a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today... | May 10, 2023
Source: marketscreener.com